Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype'. Together they form a unique fingerprint.
CYP2C19
Pharmacology, Toxicology and Pharmaceutical Science
100%
Fluvoxamine
Pharmacology, Toxicology and Pharmaceutical Science
100%
Pharmacokinetics
Pharmacology, Toxicology and Pharmaceutical Science
100%
Poor Metabolizer
Keyphrases
75%
CYP2D6
Pharmacology, Toxicology and Pharmaceutical Science
37%
Omeprazole
Pharmacology, Toxicology and Pharmaceutical Science
25%
Elimination
Pharmacology, Toxicology and Pharmaceutical Science
12%
Pharmacokinetic Parameter
Pharmacology, Toxicology and Pharmaceutical Science
12%
Cite this